Following animal model data indicating the possible rejuvenating effects of blood from young donors, there have been at least 2 observational studies conducted with humans that have investigated whether donor age affects patient outcomes. Results, however, have been conflicting. OBJECTIVE To study the association of donor age and sex with survival of patients receiving transfusions.
T he possible negative health effects linked to particular characteristics of transfused blood units have received much attention in recent years. Much of this research has focused on the health effects of stored blood products. [1] [2] [3] [4] [5] [6] [7] [8] Although large observational and randomized studies have not found any negative effect of stored blood, 9-14 other characteristics of blood units are receiving increasing attention. Most recently, following reports from animal model studies suggesting that transfusions from young donors may have rejuvenating effects in older recipients, [15] [16] [17] [18] [19] [20] there have been at least 2 observational studies investigating whether donor age influences the survival of patients receiving transfusions.
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The studies used dissimilar statistical methods and reported conflicting results. In the first study, which was based on the Scandinavian Donations and Transfusions (SCANDAT2) database, 23 a matched cohort design was used, and no associations were found between donor age and mortality of patients who received transfusions. 22 The second study, based on Canadian data, used a more complex, time-dependent survival model and conversely reported increased risks of death among recipients of blood from young and female donors.
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The difference between the findings of these 2 studies is striking. If the Canadian findings are true, they would have immediate implications for transfusion medicine practice. To understand and explain these differences and ultimately reconcile the contradictory results, we conducted a new retrospective cohort study based on the SCANDAT2 database in which we used methods similar to those used in the Canadian study by Chassé et al. 21 
Methods

Data Sources
All analyses were based on the SCANDAT2 database, which has been described in detail previously. 23 In brief, the database contains all electronically available data from Sweden since 1968 and from Denmark since 1983 on blood donors, blood donations, blood components, and patients who received transfusions. Using national registration numbers that are available for all persons living in both countries, 24,25 the SCANDAT2 database has been linked with nationwide population registers, as well as registers for hospital and outpatient care, cause of death, and cancer occurrence. The creation of the SCANDAT2 database and the conduct of this study were approved by the Danish Data Protection Agency and the ethics review board in Stockholm, Sweden. Informed consent was waived by the ethics review board in Stockholm, Sweden, and the Danish Data Protection Agency.
Study Design
Blood unit allocation typically follows a first in-first out principle: when 1 or more blood units are ordered for a patient, the blood bank selects the available compatible unit(s) that had been stored the longest. Consequently, within a given hospital or administrative region, all characteristics attributed to a blood unit-apart from blood group-should be unconnected with patient characteristics. Hence, characteristics such as donor age and sex should not be associated with any prognostic factor of the patients. However, even if the blood units of interest are effectively randomly allocated, a patient who receives many transfusions overall is more likely to receive 1 or more of these units. Because underlying disease severity is linked to both the number of transfusions and the risk of death, a comparison of the risk of death among patients who did receive particular blood units of interest and those who did not can still be confounded. As such, meticulous adjustments are warranted. In this case, adjustment for the total number of transfusions will break the association between disease severity and the exposure of interest and will thus remove the confounding. More important, because the association between the number of transfusions and the risk of death is not direct, 26 this adjustment must be set up flexibly to allow nonlinear associations. In addition, because the distribution of donor age, as well as patient mortality, may differ geographically, analyses must also account for the hospital. A detailed description of the analytical background is found in the eAppendix and eFigures 1 and 2 in the Supplement. We designed a retrospective cohort study similar to the one described by Chassé et al. 21 The analyses were restricted to the period from January 1, 2003, to December 31, 2012. We included all patients who were recorded to have received at least 1 red blood cell transfusion in this period. We excluded patients who received autologous transfusions or units that could not be traced to an identified donor. Patients who received transfusions were followed up from the date of the first transfusion until death, emigration, or end of follow-up. To increase the sensitivity for short-term survival effects, we also performed analyses in which the patients were followed up for a maximum of 30 days. Given its importance in mediating the confounding effect of disease severity (eAppendix in the Supplement), we first examined the association between total number of red blood cell transfusions and risk of death using 3 separate statistical models based on the 30-day follow-up model. We fitted 1 model that incorporated only a log-linear term for number of transfusions; another model in which this variable was categorized as 1 to 10 or 11 to 20, and so on; and a third model in which number of transfusions was fitted as a restricted cubic spline with 5 knots (eAppendix in the Supplement). For each of the 3 models, we then extracted the predicted hazard ratio (HR) for all possible values for the "number of transfusions" variable, with 15 transfusions arbitrarily set as the reference. As an objective measure of model fit to compare the 3 models, we used the Akaike information criterion. 27 
Statistical Analysis
Statistical analysis was performed from September 15 to November 15, 2016. All blood units were categorized by donor age (<20, 20-29, 30-39, 40-49, 50-59, 60-69, or ≥70 years) and sex (male or female). The main exposure of interest was the number of red blood cell transfusions from donors of different age and sex. The cumulative number of transfusions of each category was allowed to change in a time-dependent manner during follow-up. Because the SCANDAT2 database records only the date and not the exact time of transfusion, exposure was allowed to change only once per day. The relative risk of death, expressed as HRs, in relation to the number of blood units from donors of a particular age or sex was estimated using Cox proportional hazards regression models. The models were set up using the Andersen-Gill counting process model. 28 More important, in all analyses, we only incorporated information that was known at the time to be represented in the model. Analyses were conducted separately for donor age and donor sex exposures. We used 2 different analytical approaches. First, we fitted 1 set of models that were similar to those in the analyses by Chassé et al. 21 Specifically, we added 1 variable for each of the exposures of interest to the same model. For the models investigating associations between donor and recipient mortality, we included 1 variable for each donor age category except for the reference category (40-49 years). These variables contained each recipient's attained number of blood units of each donor age category. Similarly, in the models of the association between donor sex and recipient mortality, we included 1 variable for the number of units originating from female donors, with blood from male donors as the reference. Because we thought that adding several highly correlated variables in the same model might lead to distorted results, we also set up an alternative approach that was different from the one used by Chassé et al. 21 We instead performed 1 statistical analysis per donor characteristic variable. For donor age, this meant 7 separate analyses (1 for each age group variable), and for donor sex, 2 separate analyses (1 for the number of units from male donors and 1 for the number of units from female donors). In each of these models, the reference category constituted recipients of all other types of units. In both of the approaches outlined, all variables for number of units of each category were fitted as log-linear terms, but to examine possible dose-response effects in more detail, we also performed analyses in which the number of units from donors of a particular age or sex was categorized as 0, 1 to 2, or 3 or more units. The categorical analysis was performed only for the second approach. For the categorized analyses, we also computed covariate-adjusted cumulative mortality for each exposure group, and cumulative mortality differences at 30 days to provide a more clinically relevant outcome measure.
Both main sets of analyses were otherwise similar and were designed to be identical to the analyses in the Canadian study, wherever possible. Adjustment was thus performed for the cumulative number of transfusions, patient age, patient sex, and Charlson Comorbidity Index, 29, 30 as ascertained from the respective patient register (see eTable 1 in the Supplement for coding details). Because the association between the number of transfusions and the risk of death was distinctly nonlinear on the log scale (eFigure 3 in the Supplement), we fitted this variable as a restricted cubic spline with 5 knots to account for nonlinearity (eAppendix in the Supplement). To allow comparison with the results from the study by Chassé et al, 21 in which this adjustment was performed using a log-linear term, we also fitted models adjusting for cumulative number of transfusions as a log-linear term. Because we included data from a large number of hospitals, which may differ both in donor demographics and patient mortality, we also adjusted for hospital by stratifying the Cox proportional hazards regression model for this variable.
To validate the overall statistical approach, we performed an analysis in which, instead of using the actual age and sex of the contributing donors, we assigned the donor age and donor sex of each blood unit randomly according to the donor age and sex distribution presented in the study by Chassé et al. 21 This analysis was based on the premise that receipt of 1 or more red blood cell units with a certain randomly assigned characteristic should not be causally associated with patient outcomes. 31 The analysis otherwise followed the same approach as the main analyses.
All data processing and statistical analyses were conducted using SAS statistical analysis software, version 9.4 (SAS Institute Inc). The data set for the time-dependent model was designed using the publicly available Stratify macro.
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Results
Of the 1 015 159 patients in the database who received transfusions between 2003 and 2012, a total of 981 971 received at least 1 red blood cell unit. After exclusion of 13 271 patients who received transfusions from donors with uncertain identity and 436 patients who received autologous transfusions, 968 264 patients remained for analysis. The characteristics of the study population are presented in Table 1 . The median age of the patients at the first transfusion was 73.0 years (interquartile range, 59.8-82.4 years), 550 257 (56.8%) were women, and 569 119 (58.8%) were from Sweden. eFigure 3 in the Supplement depicts the estimated association between the cumulative number of red blood cell transfusions and the HR of death when the number of transfusions was fitted as a log-linear term, a categorical term, and using a spline function. The log-linear assumption resulted in the poorest model fit (as indicated by the highest Akaike information criterion), and the model using a restricted cubic spline resulted in the best model fit. Table 2 presents the results of models investigating the association between the numbers of transfused red blood cell units from donors with particular characteristics and the mortality of transfusion recipients. When follow-up was restricted to 30 days, there was a U-shaped association, with a nadir corresponding to recipients of the most common category of blood units (donor age, 40-49 years [reference]) and significant and increasing HRs among recipients of blood from donors of successively more extreme (and, at the same time, increasingly uncommon) age groups (<20 years: HR, 1.12; 95% CI, 1.10-1.14; ≥70 years: HR, 1.25; 95% CI, 1.08-1.44). The association was attenuated but still noticeable with statistically significantly elevated HRs among recipients of blood from the youngest and oldest donors when we adjusted for cumulative number of transfusions as a log-linear term (model 1; <20 years: HR, 1.02; 95% CI, 1.00-1.05; ≥70 years: HR, 1.16; 95% CI, 1.01-1.35). More important, when adjustment for number of transfusions was performed with a restricted cubic spline function, none of the considered factors were associated with risk of death in the recipient (model 2). The HR per transfusion from a donor younger than 20 years of age was 0.98 (95% CI, 0.96-1.00). We observed similar patterns when we considered donor sex, with an HR of 0.99 (95% CI, 0.99-1.00) per unit from a female donor in the fully adjusted model. When follow-up was unrestricted during the 10-year study period, the number of units from donors younger than 20 years of age was again associated with the risk of death in model 1 (HR, 1.04; 95% CI, 1.03-1.04) but not in model 2 (HR, 1.01; 95% CI, 1.00-1.01).
Results from the second analytical approach, in which we considered the different variables for donor age and sex in separate models, are presented in eTable 2 in the Supplement.As in Table 2 , we saw statistically significant associations only in the unadjusted model and in model 1, in which we adjusted for number of red blood cell transfusions as a log-linear term. Here, associations were stronger than in Table 2 , with HRs ranging from 1.05 (95% CI, 1.04-1.05) per unit from a donor who was 50 to 59 years of age to 1.32 (95% CI, 1.14-1.52) per unit from a donor who was 70 years of age or older. With more careful adjustment for number of transfusions using restrictive cubic splines, all associations disappeared. Results from analyses with unrestricted follow-up were largely similar (eTable 2 in the Supplement).
More important, when the exposure in eTable 2 in the Supplement was categorized according to number of red blood cell transfusions of each respective blood category, no clear dose-response effects emerged (eTable 3 in the Supplement). When we compared patients who received 3 or more units with a particular characteristic with patients who received no such units, adjusted 30-day cumulative mortality differences were consistently below 0.5%, with upper 95% confidence limits no higher than 1.0% (eTable 4 in the Supplement).
The sensitivity analyses considering the effects of blood units from donors with randomly assigned age and sex are presented in Table 3 . Despite the fact that the analyses were conducted on data for which the exposure of interest was randomly assigned and for which there should thus be no genuine causal associations with the outcome, models that adjusted for the number of transfusions using a linear term produced statistically significant associations with the lowest HRs in the most common blood category and with increasing HRs with more extreme (and more uncommon) categories, just as in Table 2 . And, as in Table 2 , all associations were removed with full statistical adjustment.
Discussion
Following a recent publication from a Canadian research group reporting increased mortality among patients who received red blood cell transfusions from both young donors and female donors, 21 we set out to replicate these findings in an independent patient cohort. Using the same analytical approach as in the Canadian study, we were able to replicate their findings with some variation in point estimates. However, after adjusting more carefully for the total number of red blood cell transfusions, neither donor age nor donor sex was associated with patient mortality. Assuming our approach is correct, these findings indicate that, with regard to recipient outcomes, neither of these donor characteristics need be considered when allocating red blood cell units for transfusion. For most patients, the allocation of blood units follows very predictable rules. Typically, when a clinician orders a blood unit for a patient, the local blood bank will select the oldest available unit of a compatible blood type. Other blood unit characteristics, such as donor age and sex, can therefore be assumed to be randomly distributed among patients. When studying associations between the numbers of transfusions with a particular characteristic and the risk of death in the recipient, underlying disease severity in patients may still confound the association through total number of transfusions (eAppendix in the Supplement). However, with meticulous adjustment for total number of transfusions, it should be possible to block the confounding effect of patient disease severity entirely. This reason is why patients in a previous study of donor age and patient outcomes were matched on the number of transfusions. Because of the large size of the study cohort, with longterm follow-up and access to detailed data from populationbased health data registers, we were able to characterize the nonlinear association between number of red blood cell transfusions 33 and recipient risk of death. Based on this analysis, we created a statistical model that corrected for this factor very carefully. We then verified the adequacy of our statistical model using a simple simulation in which the age and sex of the contributing blood donors were assigned randomly. Again, this process revealed strong associations in the unadjusted model but no associations in the fully adjusted model. a The donor age and sex of each blood unit was randomly allocated according to the age and sex distributions of the donors in the study by Chassé et al.
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Percentages may not total 100% owing to rounding.
b Hazard ratios are per transfused blood unit.
c The unadjusted model only included terms for donor age/or sex. Model 1 adjusted for number of red blood cell transfusions as a log-linear term. Model 2 adjusted for number of red blood cell transfusions as a restricted cubic spline with 5 knots. All 3 models were stratified by hospital to account for regional differences. Both model 1 and model 2 also included parameters for Charlson Comorbidity Index score, sex, and age.
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Limitations
There are some differences between the study by Chassé et al 21 and our study that should be mentioned. First, there may be higher-level differences in donor demographics, blood-bank logistics, and component manufacture processes that may at least theoretically have contributed to some of the differences in the results. Moreover, it is quite likely that there are differences between the patients who received transfusions in Scandinavia and the patients who received transfusions in Canada, including mean follow-up and patient mortality, which, in turn, may affect relative risk magnitudes. The key difference between the 2 studies is rather the difference in adjusting for the key confounding factor, number of transfusions, in which we show that insufficient attention to this variable will result in strong associations between number of blood components from young or very old donors and recipient risk of death, even when donor age and sex were assigned randomly in a simulation. Therefore, we believe that, rather than reflecting true biological effects, the Canadian results can be explained by residual confounding (ie, that the observations resulted from incomplete adjustment for the number of transfusions).
Conclusions
The age and sex of donors of red blood cell units are unlikely to influence the survival of patients receiving transfusions. In addition, we believe these data reinforce the importance of extreme caution in assessing epidemiologic analyses in this field given the tremendous clinical and logistical implications of false-positive findings. Allogeneic blood transfusions involve complex biological products prepared from donated blood and are considered unique in many respects compared with other health care therapeutics. Blood donors are a demographically and genetically diverse group of individuals with inherited differences that may affect the stability of and outcomes associated with transfused blood components. Given the inherent variation in donated blood, most countries use a regulatory authority, such as the US Food and Drug Administration, to monitor factors associated with blood collection, manipulation, storage, and safety. Following significant advances in the reduction of infectious risks that have been associated with allogeneic blood transfusion during the past 2 decades, there has been a concerted effort to understand and improve the quality and potency of donated blood components. Recent efforts have been devoted to understanding the effect of blood processing methods, storage solutions, and duration of blood product storage on the quality of the product.
Attention has shifted to examining the effect of product quality on noninfectious adverse events after blood transfusion. An example of this is transfusion-related acute lung injury, a rare but potentially fatal complication thought to be associated with the presence of anti-human leukocyte antigen antibodies in transfused blood. These antibodies are more common in multiparous women and the deferral of some female donors for plasma and platelet blood products led to dramatic declines in the incidence-but not the elimination-of this pulmonary transfusion reaction. More recently, animal and human studies have increased attention on the role of factors in the blood of young individuals and clinical outcomes. [1] [2] [3] [4] The widespread use of electronic health records has led to the opportunity to investigate the potential adverse outcomes associated with transfusion therapy by linking data on blood donors, processed components, and transfusion recipient outcomes. In this issue of JAMA Internal Medicine, Edgren and colleagues 5 provide additional insights into the association of blood donor factors with recipient survival after transfusion of red blood cells. The investigators replicated the analytic model previously published by a group of Canadian investigators who found increased mortality in recipients of blood from female donors and younger donors. 4 The longitudinal cohort study by
Edgren et al 5 linked data on blood donors with transfusion recipient outcomes from administrative databases containing comorbid diagnoses and mortality outcomes in Sweden and Denmark. As in the previous study, Edgren et al 5 examined the association between specific exposures (donor age and sex) and the primary outcome (transfusion recipient survival), but they included different approaches to controlling for potential confounding associated with the total number of units transfused. It is worth reiterating that blood allocation is principally determined by a transfusion recipient's blood type and not from other characteristics of the blood donor, including age or sex. Given lack of clinical awareness of donor characteristics, one can expect random distribution of blood from male or female donors and from various age groups; therefore, epidemiologic study of these exposures would not be expected at first glance to be limited by confounding. 
eAppendix. Detailed Methodological Considerations
Why is meticulous adjustment for total number of transfusions so important in this situation?
Blood allocation routines which typically follows a first in first out principle whereby only donor blood group is considered when selecting a blood unit for a patient in need of transfusion ensures that non blood group factors are randomly distributed between patients (owever as has been noted the probability of receiving a blood unit with a particular characteristic will increase with the cumulative number of transfusions The causal diagram in eFigure depicts the causal structure of the studied association There are causal pathways from patient disease severity to both the exposure exposure to uncommon blood unit and the outcome death Thus patient disease severity fulfils the criteria of a genuine confounding factor (owever on account of the blood allocation principles the causal pathway to the exposure goes only via total number of transfusions where the latter variable determines the probability that a patient receives one or more units with an uncommon trait Total number of transfusions thus acts as a mediator of the causal effect of patient disease severity on the exposure )t is thus clear that careful adjustment for the comparatively simple variable number of transfusions can serve to remove all confounding from the more complex patient disease severity Therefore if meticulous adjustment for total number of transfusions can be attained the causal link between patient disease severity and the exposure will be blocked see eFigure
Then patient disease severity is no longer a confounding factor for the studied association )n fact given that the nebulous concept patient disease severity is notoriously difficult to measure exactly let alone adjust for adjustment for total number of transfusions is effectively the only efficient way of controlling for patient disease severity in this situation )ndeed this is supported by the lack of effect of further adjustment for © 2017 American Medical Association. All rights reserved.
Charlson comorbidity index once the models sufficiently carefully accounted for total number of transfusions data not shown
Why adjustments accommodating non linear relationships?
The relationship between total number of transfusions and exposure to uncommon blood unit is based on simple mathematics and clearly linear On the other hand the causal pathway from patient disease severity to total number of transfusions cannot be easily assessed due to the measurement problems alluded to in the foregoing As part of the preparatory work for the present analyses we instead investigated the relationship between total number of transfusions and death This relationship was markedly non linear eFigure As can be predicted from eFigure it is likely that most or all of the observed relationship between total number of transfusions and death is in fact driven by patient disease severity )f the latter variable i e patient disease severity is operationalized as the condition specific inherent risk of dying which captures the essence of the variable better a linear relationship with the outcome death can be assumed Then the observed non linearity of the association between total number of transfusions and death must be attributed to the non linear relationship between patient disease severity and total number of transfusions Clearly the strongest support for the assumption that the analyses must account for the non linear nature of the relationship derives from our observation that adjustments accommodating non linear relationships were needed in order to break the link and fully eliminate the confounding in the simulated analyses
As verified both in our real data and in our simulation with age and sex being allocated randomly the effect sizes i e the magnitude of the confounding increased with increasing
